| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.4 | 0.3 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.18 | 0.03 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.17 | 8e-06 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-05 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |